Autoimmune And Inflammation Transplant Rejection or Transplantation

Table of Contents

RECENT HIGHLIGHTS AND CHANGES
--Recent Highlights and Changes
Transplant Rejection or Transplantation Pipeline Overview
--% of Projects (By Phase of Development)
--No. of Projects by Phase of Development
--Marketed Products Vs. Pipeline Products
Company Overview - Pipeline Projects
--Company Overview - Pipeline Projects

--Top Companies in late stage Transplant Rejection or Transplantation Projects
--Astellas Pharma Inc
--APT Pharmaceuticals Inc.
--Daewoong Pharmaceutical Co. Ltd.
--Bristol-Myers Squibb Company
--Fresenius AG
--Dompe S.p.A.
--Isotechnika Inc.
--Genzyme Corporation
--LifeCycle Pharma
--Kiadis Pharma B.V.
--Norwood Immunology Limited
--Nabi Biopharmaceuticals
--Pfizer Inc
--Novartis AG
--RECORDATI SpA
--Pharmalink AB
--Roche Holdings Ltd
--Repligen Corporation
--Y' s Therapeutics Co., Limited
--Wyeth

--Top Companies in early stage Transplant Rejection or Transplantation Projects
--Alexion Pharmaceuticals Inc
--Active Biotech
--Astellas Pharma Inc
--Argos Therapeutics, Inc.,
--erly Merix Bioscience)
--BioCryst Pharmaceuticals Inc
--Avontec GmbH
--Debiopharm Group
--Cellerant Therapeutics, Inc.
--Genmab A/S
--Genentech Inc
--Isotechnika Inc.
--Genzyme Corporation
--LifeCycle Pharma
--Kyorin Co., Ltd.
--TaiGen Biotechnology Co., Ltd.
--Pharmagenesis Inc
--Tolerx, Inc.
--Talecris Biotherapeutics
--Warren Pharmaceuticals, Inc.
--Viron Therapeutics Inc

Pipeline Revenue
--Pipeline Revenue
Full Pipeline View
--Pre Clinical Pipeline View
--Phase I Pipeline View
--Phase II Pipeline View
--Phase III Pipeline View
--Pending Approval Pipeline View
--Post Marketing Pipeline View
--On the Market Pipeline View
--Discovery/Development Pipeline View